2. Gene
  3. KDR - kinase insert domain receptor Gene

KDR - kinase insert domain receptor Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Macaca fascicularis
Gene ID: 102136227 | Gene type: protein coding

About KDR

Primary_assembly 5: 78,970,505-79,016,167 forward strand.Macaca_fascicularis_6.0:CM021943.1

This gene has 1 transcript (splice variant), 199 orthologues and 55 paralogues.

KDR Products(2)

mRNA Protein Name
XM_005555270.3 XP_005555327.2 vascular endothelial growth factor receptor 2
XM_005555270.3 XP_005555327.2 vascular endothelial growth factor receptor 2
Protein Preferred Names Protein Names

vascular endothelial growth factor receptor 2

kinase insert domain receptor (a type III receptor tyrosine kinase)

Related Agents

Approval
Bioactive Molecules (7)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-10260 Vandetanib 99.95% Yes
HY-112306 Ripretinib 98.90% Yes
HY-14914 Azilsartan 99.51% Unkown
HY-10330 Toceranib Inhibitor 96.86% Unkown
HY-10330A Toceranib phosphate Inhibitor 98.54% Unkown
HY-10260B Vandetanib hydrochloride / Unkown
HY-10260A Vandetanib trifluoroacetate / Unkown
Clinical Phase
Bioactive Molecules (16)
Cat. No. Product Name Effect
Purity Phase
HY-50751 Linifanib 99.28% Phase 3
HY-10205 Cediranib 99.58% Phase 3
HY-13314 Tesevatinib Inhibitor 99.21% Phase 3
HY-12018 Vatalanib dihydrochloride 99.91% Phase 3
HY-13049 Cediranib maleate 99.95% Phase 3
HY-10203 Vatalanib Inhibitor 99.93% Phase 3
HY-12018A Vatalanib hydrochloride Inhibitor / Phase 3
HY-50751G Linifanib (GMP) Inhibitor / Phase 3
HY-110272 Vatalanib succinate Inhibitor / Phase 3
HY-10374 Semaxinib Inhibitor 99.96% Phase 2
HY-13024 Rebastinib 99.91% Phase 2
HY-10338 Foretinib Inhibitor 99.23% Phase 2
HY-10987A ENMD-2076 99.12% Phase 2
HY-10987 ENMD-2076 Tartrate 99.42% Phase 2
HY-10204 OSI-930 98.57% Phase 1
HY-100315 XL 999 Inhibitor 99.34% Phase 1
Inhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Phase
HY-P99830 Conbercept / Phase 4
HY-P99768 Olinvacimab Inhibitor 95.00% Phase 2
Pre-clinical Phase
Bioactive Molecules (37)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-12299 WH-4-023 Inhibitor 99.75% Unkown
HY-151361 AMPK-IN-3 Inhibitor 98.51% Unkown
HY-W062835 CGP77675 Inhibitor 99.00% Unkown
HY-13561 AZM475271 Inhibitor 99.85% Unkown
HY-13838 PLX647 Inhibitor 99.79% Unkown
HY-133551 WF-47-JS03 Inhibitor 99.63% Unkown
HY-101219 VEGFR-IN-1 Inhibitor 98.42% Unkown
HY-132135 (1E)-CFI-400437 dihydrochloride Inhibitor 98.08% Unkown
HY-15769 WHI-P180 Inhibitor 99.62% Unkown
HY-18302 c-Kit-IN-5-1 Inhibitor 98.16% Unkown
HY-125741 GW768505A free base Inhibitor 98.66% Unkown
HY-10517A (Z)-Orantinib Inhibitor 99.44% Unkown
HY-13785 ZM 306416 Inhibitor 99.80% Unkown
HY-119757 Tyrphostin AG1433 Inhibitor 99.08% Unkown
HY-15814 HG-7-85-01 99.94% Unkown
HY-100824 PP2 Analog Inhibitor / Unkown
HY-10260S Vandetanib-d6 / Unkown
HY-10260S1 Vandetanib-d4 / Unkown
HY-10260S2 Vandetanib-13C6 / Unkown
HY-120214 TAS05567 Inhibitor / Unkown
HY-13838A PLX647 dihydrochloride Inhibitor / Unkown
HY-14979 ML786 Inhibitor / Unkown
HY-14979A ML786 dihydrochloride Inhibitor / Unkown
HY-15334 CEP-5214 Inhibitor / Unkown
HY-168114 Multi-kinase inhibitor 3 Inhibitor / Unkown
HY-168115 Multi-kinase inhibitor 4 Inhibitor / Unkown
HY-18318 Takeda-6D Inhibitor / Unkown
HY-RS07226 KDR Human Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS07227 Kdr Mouse Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-RS07228 Kdr Rat Pre-designed siRNA Set A Pre-designed Sets / Unkown
HY-W062835A CGP77675 hydrate Inhibitor / Unkown
HY-10330S Toceranib-d8 Inhibitor / Unkown
HY-110045 ZM-306416 hydrochloride Inhibitor / Unkown
HY-119757A Tyrphostin AG1433 hydrochloride Inhibitor / Unkown
HY-149451 SYHA1815 Inhibitor / Unkown
HY-15769A WHI-P180 hydrochloride Inhibitor / Unkown
HY-101628 VEGFR-2-IN-9 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens KDR NCBI NCBI:3791
Rattus norvegicus KDR NCBI NCBI:25589
Macaca mulatta KDR NCBI NCBI:698293